Studies have shown that Stigmasterol can inhibit the proliferation of gastric cancer cells, and induce apoptosis and autophagy by blocking the AKT/mTOR signaling pathway, and autophagy has a protective effect on apoptosis. The gene discussed is AKT1; the disease is gastric cancer.